JP2021520355A5 - - Google Patents

Info

Publication number
JP2021520355A5
JP2021520355A5 JP2020554092A JP2020554092A JP2021520355A5 JP 2021520355 A5 JP2021520355 A5 JP 2021520355A5 JP 2020554092 A JP2020554092 A JP 2020554092A JP 2020554092 A JP2020554092 A JP 2020554092A JP 2021520355 A5 JP2021520355 A5 JP 2021520355A5
Authority
JP
Japan
Prior art keywords
double
nucleic acid
stranded nucleic
acid inhibitor
inhibitor molecule
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2020554092A
Other languages
English (en)
Japanese (ja)
Other versions
JP2021520355A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2019/027021 external-priority patent/WO2019200124A1/en
Publication of JP2021520355A publication Critical patent/JP2021520355A/ja
Publication of JP2021520355A5 publication Critical patent/JP2021520355A5/ja
Withdrawn legal-status Critical Current

Links

JP2020554092A 2018-04-13 2019-04-11 Tm上昇ヌクレオチドで修飾された二本鎖核酸阻害剤分子 Withdrawn JP2021520355A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201862657428P 2018-04-13 2018-04-13
US62/657,428 2018-04-13
US201862778755P 2018-12-12 2018-12-12
US62/778,755 2018-12-12
PCT/US2019/027021 WO2019200124A1 (en) 2018-04-13 2019-04-11 Double-stranded nucleic acid inhibitor molecules modified with tm-increasing nucleotides

Publications (2)

Publication Number Publication Date
JP2021520355A JP2021520355A (ja) 2021-08-19
JP2021520355A5 true JP2021520355A5 (cg-RX-API-DMAC7.html) 2022-04-14

Family

ID=68161339

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2020554092A Withdrawn JP2021520355A (ja) 2018-04-13 2019-04-11 Tm上昇ヌクレオチドで修飾された二本鎖核酸阻害剤分子

Country Status (10)

Country Link
US (1) US11873488B2 (cg-RX-API-DMAC7.html)
EP (1) EP3773609A4 (cg-RX-API-DMAC7.html)
JP (1) JP2021520355A (cg-RX-API-DMAC7.html)
KR (1) KR20200144100A (cg-RX-API-DMAC7.html)
CN (1) CN111971051A (cg-RX-API-DMAC7.html)
AU (1) AU2019252529A1 (cg-RX-API-DMAC7.html)
CA (1) CA3094008A1 (cg-RX-API-DMAC7.html)
IL (1) IL277813A (cg-RX-API-DMAC7.html)
MX (1) MX2020010802A (cg-RX-API-DMAC7.html)
WO (1) WO2019200124A1 (cg-RX-API-DMAC7.html)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7535047B2 (ja) * 2018-12-12 2024-08-15 ディセルナ ファーマシューティカルズ インコーポレイテッド トリループを含む二本鎖核酸インヒビター分子
WO2020226960A1 (en) 2019-05-03 2020-11-12 Dicerna Pharmaceuticals, Inc. Double-stranded nucleic acid inhibitor molecules with shortened sense strands
JP2024518564A (ja) * 2021-05-11 2024-05-01 ディセルナ ファーマシューティカルズ インコーポレイテッド 中枢神経系のニューロンを標的とするための脂質コンジュゲーション
WO2023069707A2 (en) * 2021-10-22 2023-04-27 Sirnaomics, Inc. Products and compositions
JP7877458B2 (ja) * 2021-12-01 2026-06-22 ディセルナ ファーマシューティカルズ インコーポレイテッド Apoc3発現を調節するための組成物及び方法
EP4495241A1 (en) * 2022-03-16 2025-01-22 Daiichi Sankyo Company, Limited Chemically-modified oligonucleotide having rnai activity
TW202430637A (zh) 2022-11-16 2024-08-01 美商戴瑟納製藥股份有限公司 Stat3靶向性寡核苷酸及其用途

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8273866B2 (en) * 2002-02-20 2012-09-25 Merck Sharp & Dohme Corp. RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (SINA)
US8426378B2 (en) 2008-03-21 2013-04-23 Isis Pharmaceuticals, Inc. Oligomeric compounds comprising tricyclic nucelosides and methods for their use
WO2010033225A2 (en) * 2008-09-22 2010-03-25 Dicerna Pharmaceuticals, Inc. Compositions and methods for the specific inhibition of gene expression by dsrna possessing modifications
US20110288147A1 (en) 2008-09-22 2011-11-24 Bob Dale Brown Compositions and methods for the specific inhibition of gene expression by DSRNA containing a tetraloop
KR20110110776A (ko) * 2008-12-18 2011-10-07 다이서나 파마수이티컬, 인크. 유전자 발현의 특이적 억제를 위한 연장된 다이서 기질 제제 및 방법
JP6010458B2 (ja) * 2009-04-03 2016-10-19 ダイセルナ ファーマシューティカルズ, インコーポレイテッドDicerna Pharmaceuticals, Inc. 非対称二本鎖rnaによる特異的阻害のための、方法および組成物
US20140011860A1 (en) 2010-07-19 2014-01-09 Isis Pharmaceuticals, Inc. Compounds and methods for modulating target nuclear and sub-nuclear nucleic acid molecules in cells and animals
EP2850092B1 (en) 2012-04-09 2017-03-01 Ionis Pharmaceuticals, Inc. Tricyclic nucleic acid analogs
JP6326433B2 (ja) 2013-03-15 2018-05-16 ウニヴェルジテート ベルン 三環式ヌクレオシド及びそれから調製されるオリゴマー化合物
MX364814B (es) * 2013-03-15 2019-05-08 Miragen Therapeutics Inc Nucleosidos biciclicos unidos en puente.
CA2916499A1 (en) * 2013-07-03 2015-01-08 Dicerna Pharmaceuticals, Inc. Methods and compositions for the specific inhibition of alpha-1 antitrypsin by double-stranded rna
AU2014360314B2 (en) * 2013-12-06 2018-04-26 Dicerna Pharmaceuticals, Inc. Methods and compositions for the specific inhibition of transthyretin (TTR) by double-stranded RNA
EP3119789B1 (en) 2014-03-17 2020-04-22 Ionis Pharmaceuticals, Inc. Bicyclic carbocyclic nucleosides and oligomeric compounds prepared therefrom
US10351854B2 (en) * 2014-10-10 2019-07-16 Dicerna Pharmaceuticals, Inc. Therapeutic inhibition of lactate dehydrogenase and agents therefor
EP3865576A1 (en) * 2014-12-15 2021-08-18 Dicerna Pharmaceuticals, Inc. Ligand-modified double-stranded nucleic acids
US10036017B2 (en) * 2015-02-17 2018-07-31 Dicerna Pharmaceuticals, Inc. Methods and compositions for the specific inhibition of complement component 5(C5) by double-stranded RNA
WO2018045317A1 (en) * 2016-09-02 2018-03-08 Dicerna Pharmaceuticals, Inc. 4'-phosphate analogs and oligonucleotides comprising the same
US10675295B2 (en) * 2017-06-29 2020-06-09 Dicerna Pharmaceuticals, Inc. Compositions and methods for inhibiting HMGB1 expression

Similar Documents

Publication Publication Date Title
JP7535047B2 (ja) トリループを含む二本鎖核酸インヒビター分子
JP2022525208A5 (cg-RX-API-DMAC7.html)
US11873488B2 (en) Double-stranded nucleic acid inhibitor molecules modified with Tm-increasing nucleotides
JP2025000693A (ja) Appの発現を低減するための化合物及び方法
JP7394137B2 (ja) Hsd17b13発現のモジュレータ
JP7446443B2 (ja) Smn2を調節するための化合物及び方法
JP2022530678A5 (cg-RX-API-DMAC7.html)
US20230416742A1 (en) Compositions and methods for inhibiting mapt expression
WO2016040748A1 (en) Compositions and methods for detection of smn protein in a subject and treatment of a subject
EP4323518A2 (en) Compositions and methods for inhibiting ketohexokinase (khk)
US12529053B2 (en) Double-stranded nucleic acid inhibitor molecules with shortened sense strands
CA3190481A1 (en) Compositions and methods for inhibiting plp1 expression
JP2024528503A5 (cg-RX-API-DMAC7.html)
CN119403927A (zh) 用于抑制跨膜丝氨酸蛋白酶6(tmprss6)表达的组合物和方法
CN118979036A (zh) 抑制APP基因表达的siRNA及其缀合物和应用
JP2023530072A (ja) Pmp22を調節するための化合物及び方法
CA3250061A1 (en) Compositions and methods for inhibiting the expression of SNCA
CN115279904A (zh) 抑制asah1基因表达的组合物和方法
HK40083632A (en) Compositions and methods for inhibiting asah1 gene expression
KR20260049590A (ko) Tubb4a 발현을 감소시키기 위한 화합물 및 방법
CN121718537A (zh) 用于血脂异常等相关疾病的siRNA及其缀合物和应用
JP2024528417A5 (cg-RX-API-DMAC7.html)